INIS
ovaries
100%
androgens
63%
reductases
45%
steroids
36%
women
27%
metabolites
27%
genetics
18%
tissues
18%
diseases
18%
production
18%
control
18%
metabolism
18%
weight
18%
dehydrogenases
18%
excretion
18%
design
9%
levels
9%
animals
9%
mass spectrometry
9%
adults
9%
comparative evaluations
9%
medical centers
9%
length
9%
variations
9%
hypothesis
9%
pathogenesis
9%
programming
9%
blood
9%
precursor
9%
gas chromatography
9%
Medicine and Dentistry
Polycystic Ovary Syndrome
100%
Oxidoreductase
45%
Androgen
27%
Steroid Metabolite
27%
Woman
27%
Childhood
27%
Hydroxysteroid Dehydrogenase
18%
Target Tissue
18%
Age
18%
Androgen Synthesis
18%
Androgen Metabolism
18%
Girl
18%
Urinary System
18%
Diseases
9%
Development
9%
Pathogenesis
9%
Excretion
9%
Genetic Disorder
9%
Precursor
9%
Developmental Stage
9%
Cord Blood
9%
Genetic Variation
9%
Critical Period (Psychology)
9%
Adult
9%
Gas Chromatography Mass Spectrometry
9%
Biochemistry, Genetics and Molecular Biology
Reductase
45%
Childhood
27%
Age
18%
Hydroxysteroid Dehydrogenase
18%
Target Tissue
18%
Androgen Synthesis
18%
Androgen Metabolism
18%
Steroid Urine Level
18%
Weight
18%
Tetrahydrocortisol
18%
Development
9%
Mutation
9%
Excretion
9%
Steroid
9%
Precursor
9%
Gas Chromatography-Mass Spectrometry
9%
Critical Period (Psychology)
9%
Animal Models
9%
Length
9%
Genetic Disorder
9%
Steroid Excretion
9%